The 1AH2 clone (subclone of 53A2) has been reported to react with CD137, a member of the TNFR/NGFR superfamily. The expression of CD137 has been reported to be detectable from day 3 and peaks around day 6 after activation with ConA, PMA plus ionomycin, or immobilized anti-CD3e (Cat. No. 553058). Monomers, dimers, or tetramers of the 4-1BB antigen are expressed, upon activation, on the surface of splenic T lymphocytes, thymocytes, intestinal intraepithelial T lymphocytes (IEL), and some T cell lines and clones. While stimulating T cells by IL-2, IL-4, or anti-CD28 alone does not result in the expression of CD137, addition of IL-2, IL-4, anti-CD28, or syngeneic accessory cells to splenic T cells stimulated via TCR/CD3 can result in a high level of CD137 expression. CD137 has also been reported to be observed on IL-2 activated NK cells, but not on freshly isolated NK cells. It has been demonstrated that 4-1BB physically associates with p56 [lck]through a Cys-Arg-Cys-Pro binding site in its cytoplasmic domain, the same motif in the cytoplasmic tail of the CD4 and CD8a molecules is responsible for association with p56 [lck]. A signaling function for the CD137 Molecule in mouse T cells is indicated by reports in which cross-linking of CD137 with 1AH2 mAb resulted in enhanced proliferation of CD3e-activated splenic T cells and IEL and in enhanced cytolytic activity of IEL in response to immobilized anti-CD3e. In addition to extracellular matrix proteins which bind to CD137, a 97- kDa dimer of the TNF/NGF superfamily has been reported to be a ligand for 4-1BB (4-1BBL). This molecule has been detected on Con A-activated T cells, LPS-activated macrophages, and anti-μ-activated splenic B cells. Interaction between T and B cells through 4-1BB/4-1BBL is reported to play a role in antigen presentation, further supporting a costimulatory role for CD137 in the immune response of T lymphocytes. This antibody is routinely tested by flow cytometric analysis. Other applications were tested during antibody development only or reported in the literature.
BD Pharmingen™ Biotin Rat Anti-Mouse CD137 - Biotin - Clone 1AH2 - Isotype Rat IgG1, κ - Reactivity Ms - 0.1 mg
Purification
The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
The antibody was conjugated with biotin under optimum conditions, and unreacted biotin was removed.
Stock
4 °C
Stockage commentaire
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Takeda, Oshima, Hayakawa, Akiba, Atsuta, Kobata, Kobayashi, Ito, Yagita, Okumura: "CD27-mediated activation of murine NK cells." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 164, Issue 4, pp. 1741-5, (2000) (PubMed).
Saoulli, Lee, Cannons, Yeh, Santana, Goldstein, Bangia, DeBenedette, Mak, Choi, Watts: "CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand." dans: The Journal of experimental medicine, Vol. 187, Issue 11, pp. 1849-62, (1998) (PubMed).
DeBenedette, Shahinian, Mak, Watts: "Costimulation of CD28- T lymphocytes by 4-1BB ligand." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 158, Issue 2, pp. 551-9, (1997) (PubMed).
Hurtado, Kim, Kwon: "Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 158, Issue 6, pp. 2600-9, (1997) (PubMed).
DeBenedette, Chu, Pollok, Hurtado, Wade, Kwon, Watts: "Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP." dans: The Journal of experimental medicine, Vol. 181, Issue 3, pp. 985-92, (1995) (PubMed).
Hurtado, Kim, Pollok, Lee, Kwon: "Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 155, Issue 7, pp. 3360-7, (1995) (PubMed).
Pollok, Kim, Kwon: "Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4." dans: European journal of immunology, Vol. 25, Issue 2, pp. 488-94, (1995) (PubMed).
Zhou, Pollok, Kim, Kim, Kwon: "Functional analysis of T-cell antigen 4-1BB in activated intestinal intra-epithelial T lymphocytes." dans: Immunology letters, Vol. 41, Issue 2-3, pp. 177-84, (1995) (PubMed).
Kim, Pollok, Zhou, Shaw, Bohlen, Fraser, Kwon: "Novel T cell antigen 4-1BB associates with the protein tyrosine kinase p56lck1." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 151, Issue 3, pp. 1255-62, (1993) (PubMed).
Pollok, Kim, Zhou, Hurtado, Kim, Pickard, Kwon: "Inducible T cell antigen 4-1BB. Analysis of expression and function." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 150, Issue 3, pp. 771-81, (1993) (PubMed).
Chalupny, Peach, Hollenbaugh, Ledbetter, Farr, Aruffo: "T-cell activation molecule 4-1BB binds to extracellular matrix proteins." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 89, Issue 21, pp. 10360-4, (1992) (PubMed).
Antigène
CD137 (TNFRSF9)
(Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9))